China Shineway Pharmaceutical Group Limited CSWYF
1.00 USD 0.00 (+0.00%)
Regular-session close
0.9253 Day range 0.9253
1.00 52-week range 1.00
- YTD
- +0.40%
- 1 year
- +0.40%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
4.19 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 5.5×
P/S 1.7×
P/B 0.7×
P/FCF 5.4×
EV/EBITDA -1.2×
EV/Sales -0.5×
FCF Yield 18.4%
Profitability
Gross Margin 72.3%
Operating Margin 22.9%
Net Margin 30.3%
ROE 11.8%
ROIC 6.2%
ROA 8.8%
Growth (YoY)
Revenue -17.0%
Operating Income -14.8%
EPS (diluted) 13.5%
Free Cash Flow 18.4%
Financial Health
Current Ratio 3.7×
Quick Ratio 3.4×
Debt / Equity 0.0×
Net Debt / EBITDA -5.1×
Interest Coverage 126×
Dividends
Dividend Yield 6.7%
Payout Ratio 37.4%
Annual · latest fiscal year ends 2025-12-31
